Pasar al contenido principal

IMPLICACIONES DE LA PROTEINA PRECURSORA AMILOIDE (APP): NEURODESARROLLO Y ENFERMEDAD DE ALZHEIMER

PID2021-126715OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases.

  • Coronel Lopez, Raquel
  • González-Sastre, Rosa
  • Mateos-Martínez, Patricia
  • Maeso Cuesta, Laura
  • Llorente-Beneyto, Elena
  • Martín-Benito, Sabela
  • Costa Gagosian, Viviana S
  • Foti, Leonardo
  • González-Caballero, MCarmen
  • López-Alonso, Victoria
  • Liste-Noya, Isabel
The brain is the most complex human organ, and commonly used models, such as two-dimensional-cell cultures and animal brains, often lack the sophistication needed to accurately use in research. In this context, human cerebral organoids have emerged as valuable tools offering a more complex, versatile, and human-relevant system than traditional animal models, which are often unable to replicate the intricate architecture and functionality of the human brain. Since human cerebral organoids are a state-of-the-art model for the study of neurodevelopment and different pathologies affecting the brain, this field is currently under constant development, and work in this area is abundant. In this review, we give a complete overview of human cerebral organoids technology, starting from the different types of protocols that exist to generate different human cerebral organoids. We continue with the use of brain organoids for the study of brain pathologies, highlighting neurodevelopmental, psychiatric, neurodegenerative, brain tumor, and infectious diseases. Because of the potential value of human cerebral organoids, we describe their use in transplantation, drug screening, and toxicology assays. We also discuss the technologies available to study cell diversity and physiological characteristics of organoids. Finally, we summarize the limitations that currently exist in the field, such as the development of vasculature and microglia, and highlight some of the novel approaches being pursued through bioengineering.